Zobrazeno 1 - 10
of 163
pro vyhledávání: '"Barrans, S"'
Autor:
McMillan, A.K., Phillips, E.H., Kirkwood, A.A., Barrans, S., Burton, C., Rule, S., Patmore, R., Pettengell, R., Ardeshna, K.M., Lawrie, A., Montoto, S., Paneesha, S., Clifton-Hadley, L., Linch, D.C.
Publikováno v:
In Annals of Oncology September 2020 31(9):1251-1259
Publikováno v:
In Aerospace Science and Technology March 2020 98
Publikováno v:
In Precision Engineering October 2016 46:158-165
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Metallurgical & Materials Transactions. Part A; Jan2023, Vol. 54 Issue 1, p121-140, 20p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Davies, A, Cummin, TE, Barrans, S, Maishman, T, Mamot, C, Novak, U, Caddy, J, Stanton, L, Kazmi-Stokes, S, McMillan, A, Fields, P, Pocock, C, Collins, GP, Stephens, R, Cucco, F, Clipson, A, Sha, C, Tooze, R, Care, MA, Griffiths, G, Du, M-Q, Westhead, DR, Burton, C, Johnson, PWM
Publikováno v:
Davies, Andrew; Cummin, Thomas E; Barrans, Sharon; Maishman, Tom; Mamot, Christoph; Novak, Urban; Caddy, Josh; Stanton, Louise; Kazmi-Stokes, Shamim; McMillan, Andrew; Fields, Paul; Pocock, Christopher; Collins, Graham P; Stephens, Richard; Cucco, Francesco; Clipson, Alexandra; Sha, Chulin; Tooze, Reuben; Care, Matthew A; Griffiths, Gareth; ... (2019). Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial. The lancet oncology, 20(5), pp. 649-662. Elsevier 10.1016/S1470-2045(18)30935-5
BACKGROUND: Biologically distinct subtypes of diffuse large B-cell lymphoma can be identified using gene-expression analysis to determine their cell of origin, corresponding to germinal centre or activated B cell. We aimed to investigate whether addi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0ca200ca0986b184f9bd9d47ac4e133
Autor:
Sha, C, Barrans, S, Cucco, F, Bentley, MA, Care, MA, Cummin, T, Kennedy, H, Thompson, JS, Uddin, R, Worrillow, L, Chalkley, R, van Hoppe, M, Ahmed, S, Maishman, T, Caddy, J, Schuh, A, Mamot, C, Burton, C, Tooze, R, Davies, A, Du, MQ, Johnson, PWM, Westhead, DR
Purpose: Biologic heterogeneity is a feature of diffuse large B-cell lymphoma (DLBCL), and the existence of a subgroup with poor prognosis and phenotypic proximity to Burkitt lymphoma is well known. Conventional cytogenetics identifies some patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::9f124f785fb6f5f4abacacd2791c7a90
https://eprints.whiterose.ac.uk/138128/17/jco.18.01314.pdf
https://eprints.whiterose.ac.uk/138128/17/jco.18.01314.pdf
Autor:
Radhakrishnan, V. S., Stanton, L., Caddy, J., Keyworth, N., Saunders, G., Barrans, S., Rafferty, J., Joyce, T., Collins, G. P., Barrington, S., Warbey, V., Fox, C., Burton, C., Griffiths, G., Johnson, P., Davies, A. J.
Publikováno v:
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p166-167, 2p